Clinical Trials on Cancer. in Germany

Total 2356 results

AIO-Studien-gGmbH
Bristol-Myers Squibb

Completed

A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer (RAMONA)

Esophageal Cancer | Gastrooesophageal Cancer | Oesophageal Cancer | GastroEsophageal Cancer | Esophageal Cancers NOS | Oesophageal Cancer Metastatic | Esophageal Cancer Metastatic | Oesophageal Cancer Nos

Germany
University Hospital, Essen

Not yet recruiting

Optimization of Radiation Protection Through Genomic Analyses (ORtogether)

Cancer | Radiation | DNA

Germany
Charite University, Berlin, Germany

Completed

Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients

Gastric Cancer | Colorectal Cancer | Esophageal Cancer

Germany
German Breast Group
Roche Pharma AG; Celgene Corporation

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (GeparSepto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
German Breast Group
Celgene Corporation; Amgen

Completed

Denosumab as an add-on Neoadjuvant Treatment (GeparX) (GeparX)

Inflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III

Germany
University Medicine Greifswald

Completed

Nutrition in Gastrointestinal Tumors (NutriGIT)

Gastric Cancer | Pancreatic Cancer | Small Intestine Cancer | Rectal Cancer | Neuroendocrine Tumors | Bile Duct Cancer | Colon Cancer | Liver Cancer | Oesophageal Cancer | GIST, Malignant

Germany
Charite University, Berlin, Germany

Recruiting

Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer (PRIME)

Cancer

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Implementation of Shared Decision-Making in Cancer Care (PREPARED)

Cancer

Germany
Universitätsmedizin Mannheim
Hector-Stiftung; humediQ global GmbH, Grünwald; Vitaphone GmbH, Mannheim

Completed

Telemonitoring of Geriatric Cancer Patients Using Handheld Devices

Cancer

Germany
Cardiovascular and Interventional Radiological...

Recruiting

Registry on Percutaneous Electrochemotherapy (RESPECT)

Primary Liver Cancer | Secondary Liver Cancer

Germany
AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
University of Leipzig

Completed

Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis (STEPPEDCARE)

Cancer

Germany
Ludwig Institute for Cancer Research

Completed

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.

Cancer | Neoplasm

Germany
Technical University of Munich
Helmholtz Zentrum München

Completed

The Munich Adrenaline Cancer Study (MACS)

Childhood Cancer

Germany
University Women's Hospital Tübingen

Unknown

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas (MAGynMA)

Gynecologic Cancer

Germany
Charite University, Berlin, Germany

Completed

Evaluation of a Oncology Day Care Unit Programme With Two Different Focuses (TK-Onko)

Cancer

Germany
GlaxoSmithKline

Completed

A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects

Neoplasms | Cancer

Germany
Thomas Seufferlein

Unknown

NEMO - an App for Side Effect Management in Oncology (NEMO)

Cancer Patients

Germany
University Hospital Tuebingen

Recruiting

Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Breast Cancer | Head and Neck Cancer | Esophageal Cancer | Rectal Cancer | Prostate Cancer | Liver Cancer | Oligometastasis

Germany
University Hospital Heidelberg
Heidelberg University; University of Jena; Martin-Luther-Universität Halle-Wittenberg and other collaborators

Recruiting

Decision Aid to Support Advanced Cancer Patients (PETUPAL)

Advanced Cancer

Germany
Technical University of Munich
Eli Lilly and Company

Recruiting

Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients (Abemacare)

Breast Cancer/ Metastatic Breast Cancer

Germany
University Hospital Heidelberg
Penn State University

Active, not recruiting

Personalized Exercise Oncology (PEXO)

Cancer | Health Behavior

Germany
PD. Dr. med. Carola Seifart
German Federal Ministry of Education and Research; Philipps University Marburg... and other collaborators

Unknown

The "Hand-in-Hand Study": Improvement of Quality of Life in Palliative Cancer Patients Through Collaborative Advance Care Planning (COLAP)

Neoplasms | Advanced Cancer | End Stage Cancer

Germany
University Hospital Tuebingen

Recruiting

Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside) (SenPET)

Cancer

Germany
Heinrich-Heine University, Duesseldorf

Completed

Prognosis and Survival Estimates in Palliative Therapy

Cancer

Germany
Technische Universität Dresden

Completed

Bevacizumab Treatment and Retinal Vessel Monitoring (BevaRet)

Cancer

Germany
University Hospital Heidelberg
Janssen-Cilag G.m.b.H; National Center for Tumor Diseases, Heidelberg

Terminated

Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage (DERANO)

Head and Neck Cancer | Anogenital Cancer

Germany
Technical University of Munich
Ludwig-Maximilians - University of Munich

Enrolling by invitation

Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

Cardiovascular Diseases | Pediatric Cancer

Germany
AIO-Studien-gGmbH
Novartis Pharmaceuticals; iOMEDICO AG

Completed

Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer (VicTORia)

Her2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast Cancer

Germany
Servier Affaires Médicales

Active, not recruiting

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan (NALLONG)

Pancreatic Cancer Metastatic

Germany
University Hospital Tuebingen
University Hospital Freiburg; University Hospital Ulm

Recruiting

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

TNBC - Triple-Negative Breast Cancer

Germany
Palleos Healthcare GmbH
Roche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...

Active, not recruiting

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy (neoMono)

Triple-negative Breast Cancer

Germany
European Organisation for Research and Treatment...

Completed

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Head and Neck Cancer | Colorectal Cancer | Metastatic Cancer

Germany
University Hospital Tuebingen

Recruiting

Molecular Tumor Board at the Center for Personalized Medicine Tübingen (MTB@ZPM)

Advanced Cancer

Germany
Krankenhaus Nordwest

Completed

Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction (S387)

Advanced Gastric Cancer | Advanced Cancer of the Esophagogastric Junction

Germany
University Hospital Freiburg

Completed

Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients

Advanced Cancer

Germany
University of Cologne

Not yet recruiting

Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients (MOMENT)

Gastric Cancer | Colorectal Cancer | Oesophageal Cancer | Duodenal Cancer

Germany
Charite University, Berlin, Germany

Not yet recruiting

Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer

Gastric and Gastroesophageal Junction Cancer

Germany
German Breast Group
Roche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor Pharma

Completed

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Inflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III

Germany
SciBase AB

Recruiting

Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

Keratinocyte Skin Cancer

Germany
Heidelberg University

Completed

PORTAS 2, Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port (PORTAS2)

Cancer

Germany
German Cancer Research Center
Heidelberg University

Completed

MOTIVACTION - Study

Cancer

Germany
University Hospital Heidelberg

Recruiting

Predicting Esophageal Cancer Borders Using PET-Imaging (PEGASUS)

Esophagus Cancer, Stage I | Esophagus Cancer, Stage II

Germany
Goethe University
Agaplesion Markus Krankenhaus gGmbH

Completed

Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy

Advanced Gastrointestinal Cancer

Germany
Apceth GmbH & Co. KG

Terminated

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 (TREAT-ME 1)

Advanced Gastrointestinal Cancer

Germany
Technische Universität Dresden
German Federal Ministry of Education and Research; AOK PLUS; Medizinische Fakultät... and other collaborators

Completed

Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research

Colorectal Cancer (CRC) and Pancreatic Cancer (PaCa)

Germany
Universität des Saarlandes

Recruiting

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Prostate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic Cancer

Germany
University of Erlangen-Nürnberg Medical School
University Hospital Erlangen; University Hospital Regensburg; University Hospital...

Recruiting

Immune Biomarker Study for Head and Neck Cancer (ImmunBio-KHT)

Head and Neck Cancer | Laryngeal Cancer | Hypopharyngeal Cancer | Oropharyngeal Cancer | Oral Cavity Cancer

Germany
TME Pharma AG
Merck Sharp & Dohme LLC

Completed

Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer (Keynote-559)

Metastatic Colorectal Cancer | Metastatic Pancreatic Cancer

Germany
AIO-Studien-gGmbH
AstraZeneca

Terminated

Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB (NeoIntercal)

NSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR Mutation

Germany

Clinical Trials on Cancer. in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations